RELAPSED/REFRACTORY B-CELL MALIGNANCIES
Clinical trials for RELAPSED/REFRACTORY B-CELL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY B-CELL MALIGNANCIES trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY B-CELL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot takes on tough blood cancers in small safety trial
Disease control Recruiting nowThis early study is testing an injection called IASO208 in 12 adults with certain types of blood cancer that have returned or not improved with standard treatments. The main goal is to see if the treatment is safe and to find the right dose. Researchers will also look at how well…
Matched conditions: RELAPSED/REFRACTORY B-CELL MALIGNANCIES
Phase: PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Experimental Dual-Target CAR-T therapy enters human testing for tough blood cancers
Disease control Recruiting nowThis early-stage study is testing a new gene therapy that reprograms a patient's own immune cells to attack two targets (CD19 and CD20) on cancer cells. The trial will enroll 30 adults with B-cell cancers that have come back or not responded to treatment. The main goals are to ch…
Matched conditions: RELAPSED/REFRACTORY B-CELL MALIGNANCIES
Phase: PHASE1 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New CAR-T therapy targets tough blood cancers in early trial
Disease control Recruiting nowThis study tests a new treatment called BAFFR CAR-T for people with B-cell blood cancers that have returned or not responded to standard therapy. The therapy uses a patient's own immune cells, modified to attack cancer cells. The goal is to see if it is safe and helps control the…
Matched conditions: RELAPSED/REFRACTORY B-CELL MALIGNANCIES
Phase: NA • Sponsor: Donghua Zhang • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New injection could train your body to fight cancer from within
Disease control Recruiting nowThis early-phase trial tests a new drug called ZZSW-01 in 6 people with B-cell blood cancers that have come back or not responded to other treatments. The drug is a special particle that carries instructions for the body to make its own cancer-fighting cells. The main goal is to …
Matched conditions: RELAPSED/REFRACTORY B-CELL MALIGNANCIES
Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New pill takes on tough blood cancers in first human trial
Disease control Recruiting nowThis early-phase trial tests an experimental oral drug called UBX-303061 in 94 adults with B-cell blood cancers (like certain lymphomas and leukemias) that have come back or not responded to at least two prior treatments. The main goals are to check safety, find the right dose, a…
Matched conditions: RELAPSED/REFRACTORY B-CELL MALIGNANCIES
Phase: PHASE1 • Sponsor: Ubix Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New hope for tough blood cancers: experimental drug AC676 enters human testing
Disease control Recruiting nowThis early-stage study tests a new drug called AC676 in about 60 adults with certain blood cancers (like leukemia or lymphoma) that returned or didn't respond to prior treatments. The main goals are to find a safe dose and understand side effects. Researchers will also check how …
Matched conditions: RELAPSED/REFRACTORY B-CELL MALIGNANCIES
Phase: PHASE1 • Sponsor: Accutar Biotechnology Inc • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC